WILLIAMSON, ET AL. 2019. J VIROL, DOI:10.1128/JVI.01439-18
Where research scientists come to find up to date resources on antibody discovery against challenging membrane protein targets.
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
FOX, ET AL. 2019. SCI IMMUNOL, 4(32): EAAV5062
Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope
LONG, ET AL. 2019. PNAS DOI: 10.1073/PNAS.1815432116.
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth
CHUKWUMA, ET AL. 2018. PLOS ONE 13(12), E0209437.
KINCHEN, ET AL. 2018. CELL HOST MICROBE 24:717-730.
In vivo delivery of synthetic human DNA-encoded monoclonal antibodies protect against ebolavirus infection in a mouse model
PATEL, ET AL. 2018. CELL REPORTS 25:1982-1993.
VAN HOUT, ET AL. BIOCHEM PHARMACOL 158:402-412.
Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection
SAPHIRE, ET AL. 2018. CELL 174(4):938-952
Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein
GILCHUK, ET AL. 2018. IMMUNITY 49(2):363-374.